Mission Bay Capital
San Francisco, Californiamissionbaycapital.com
Overview
Mission Bay Capital is an independent venture firm focused on making pivotal, early-stage investments in bioscience companies emerging from the University of California. Mission Bay Capital is fueling breakthrough bioscience technologies to meet society's challenges while also helping to boost the California economy. The firm is dedicated to helping entrepreneurial scientists create successful companies and provides early-stage funding necessary to prove out the technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| QurAlis | Mar 2023 | Series B | Co-investor |
| Nitrase Therapeutics | Nov 2021 | Series A | Co-investor |
| Asher Biotherapeutics | Sep 2021 | Series B | Co-investor |
| Alpine Bio | Jul 2021 | Series B | Co-investor |
| Alpine Biomedicals Pvt Ltd. | Jul 2021 | Series B | Co-investor |
Key People
Robert Blazej
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.